410 Medical

410 Medical

Private
Durham, North CarolinaHealthcare & Life Scienceshttps://www.410medical.com

Last Round

Series B

Extension

Mar 17, 2025

Total Funding Raised

$42.1M

Momentum Score

25 /100

Company Overview

410 Medical, Inc. is a medical device company founded in 2013 and based in Durham, North Carolina. The company develops innovative products to help frontline medical providers improve care for critically ill patients. Its flagship product, LifeFlow, is a rapid infuser designed to enhance the speed and efficiency of delivering blood and IV fluids to patients suffering from life-threatening conditions like sepsis and shock. The device received FDA clearance in 2016. 410 Medical is a privately held, venture-backed company that actively markets its products to hospitals and EMS agencies across the United States.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

rapid infuserfluid resuscitationblood and fluid infuserhemorrhage controlsepsis managementdisposable medical devicetactical combat casualty careTCCCemergency medical devicefluid bolus deviceEMS equipmentvolume resuscitationpediatric resuscitationshock treatmenthand-held infuser

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

410 Medical Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

410 Medical Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionMar 17, 2025
Series BMay 25, 2023
DebtDec 29, 2021
Series A ExtensionOct 22, 2019
VC RoundAug 22, 2018
Series A
Mar 23, 2017

Key People

Founding team and executive leadership

Kyle Chenet

CEO

Executive Team

410 Medical Investors

Notable investors and investment history

InvestorRounds
Hatteras Venture PartnersSeries B Extension, Series A Extension, Series B
OSF VenturesSeries A Extension
Catalyst by WellstarSeries B
Collective Capital VenturesVC Round
Orlando Health VenturesSeries B Extension, Series B
Ballad VenturesSeries B Extension, Series B
Sovereign's CapitalSeries A Extension, Series A

410 Medical Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

410 Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about 410 Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersDurham, North Carolina
Employee Range62
Year Founded2013
Last FundingMar 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.